A carregar...
Tocilizumab and PMX-DHP have efficacy for severe COVID-19 pneumonia
In coronavirus disease 2019 pneumonia, a cytokine storm resulting from an excessive inflammatory response to the viral infection is thought to play a role in the exacerbation of the pneumonia and its prognosis. Favipiravir and ciclesonide are not effective in the inhibition of the cytokine storm. In...
Na minha lista:
| Publicado no: | SAGE Open Med Case Rep |
|---|---|
| Main Authors: | , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
SAGE Publications
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7970680/ https://ncbi.nlm.nih.gov/pubmed/33796310 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2050313X21991063 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|